You are here

Companies

Carles Domenech, director general Ability Pharma
06.11.2015

The results come on the heels of the drug receiving FDA designation as an orphan drug

Oryzon genomics
30.10.2015

This capital increase confirms the company is valued at €96.5 millions ahead of IPO

Grants4app
28.10.2015

The projects selected are from the fields of cardiology, neurology and diagnostic imaging

Rosendo Garganta Devicare
27.10.2015

Rosendo Garganta

Founder and CEO of Devicare

Industrial engineer and electronic engineer, Rosendo was lured away by the siren call of entrepreneurialism in the health and medtech sector. After studying business administration, entrepreneurship and innovation, he founded the medtech start-up Devicare. He is also a small investor and/or board member at start-ups Rob Surgical, usMIMA and Anaconda Biomed.

Palobiopharma
28.10.2015

The Swiss multinational corporation will have the exclusive rights to develop, manufacture and market the product worldwide

Martinell Minoryx
15.10.2015

The company, which specializes in drug development for rare or minority diseases without treatment, has received €19.4

ab biotics sanofi
13.10.2015

The probiotic formula, developed by the Catalan biotechnology company, will be the first that pharmaceutical corporation Sanofi will market in Spain

Health & Bio Team Dating 2015
08.10.2015

The event, organized by Banc Sabadell, Biocat, CataloniaBio and the Bosch i Gimpera Foundation, will take place in Barcelona on 3 December

Pierre Fabre
07.10.2015

The French pharmaceutical, interested in innovative oncology projects, has met with four Catalan organizations

grants4apps
30.09.2015

The five projects selected will work at the company’s offices in Sant Joan Despí for six months, with mentoring and coaching from the group’s experts